BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-724@pharmaconomics
DTSTAMP:20260707T034701Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:MIST Approval — etripamil
DESCRIPTION:A final FDA approval decision on etripamil for paroxysmal supraventricular tachycardia (PSVT) is expected Mar 27\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1408443/000110465926059780/tm2614433d1_ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/724
URL:https://www.pharmaconomics.com/e/724
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MIST catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR